These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36314264)

  • 1. Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches.
    Merino-Vico A; Frazzei G; van Hamburg JP; Tas SW
    Eur J Immunol; 2023 Jan; 53(1):e2149675. PubMed ID: 36314264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell-Directed Therapy in Autoimmunity.
    Abeles I; Palma C; Meednu N; Payne AS; Looney RJ; Anolik JH
    Annu Rev Immunol; 2024 Jun; 42(1):103-126. PubMed ID: 38011889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selfie: Autoimmunity, boon or bane.
    Ahsan H
    J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    Baert L; Manfroi B; Casez O; Sturm N; Huard B
    J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting plasma cells in systemic autoimmune rheumatic diseases - Promises and pitfalls.
    Steinmetz TD; Verstappen GM; Suurmond J; Kroese FGM
    Immunol Lett; 2023 Aug; 260():44-57. PubMed ID: 37315847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell targeted therapies in autoimmune disease.
    Barnas JL; Looney RJ; Anolik JH
    Curr Opin Immunol; 2019 Dec; 61():92-99. PubMed ID: 31733607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibodies and antibody-secreting cells].
    Hiepe F; Dörner T
    Z Rheumatol; 2005 Sep; 64(6):389-95. PubMed ID: 16184346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting B Cells and Plasma Cells in Autoimmune Diseases.
    Hofmann K; Clauder AK; Manz RA
    Front Immunol; 2018; 9():835. PubMed ID: 29740441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
    Fetter T; Niebel D; Braegelmann C; Wenzel J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial autoimmunity participates in the regulation of rheumatoid arthritis.
    Zohar Y; Wildbaum G; Karin N
    Front Biosci; 2006 Jan; 11():368-79. PubMed ID: 16146738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Cell-Mediated Autoimmune Diseases.
    Lin X; Lu L
    Adv Exp Med Biol; 2020; 1254():145-160. PubMed ID: 32323275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-lymphocyte contributions to human autoimmune disease.
    Yanaba K; Bouaziz JD; Matsushita T; Magro CM; St Clair EW; Tedder TF
    Immunol Rev; 2008 Jun; 223():284-99. PubMed ID: 18613843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the key issue: Antigen-specific targeting of B cells in autoimmune diseases.
    Holborough-Kerkvliet MD; Kroos S; van de Wetering R; Toes REM
    Immunol Lett; 2023 Jul; 259():37-45. PubMed ID: 37209914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.
    Hiepe F; Dörner T; Hauser AE; Hoyer BF; Mei H; Radbruch A
    Nat Rev Rheumatol; 2011 Mar; 7(3):170-8. PubMed ID: 21283146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target.
    Li ZY; Cai ML; Qin Y; Chen Z
    Front Immunol; 2023; 14():1103307. PubMed ID: 36817481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
    Lou H; Ling GS; Cao X
    J Autoimmun; 2022 Oct; 132():102861. PubMed ID: 35872103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.
    Hale M; Rawlings DJ; Jackson SW
    Curr Opin Immunol; 2018 Dec; 55():81-88. PubMed ID: 30390507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.